Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (25.0%)

N/A3 (75.0%)

Trials by Status

completed375%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingnot_applicable

Packing Versus no Packing for Cutaneous Abscess

NCT02822768

completednot_applicable

Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)

NCT02638012

completednot_applicable

Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures

NCT02535624

completedphase_4

The Effect of Packing in Post Operative Management of FESS

NCT00793117

Clinical Trials (4)

Showing 4 of 4 trials

NCT02822768Not Applicable

Packing Versus no Packing for Cutaneous Abscess

Recruiting

NCT02638012Not Applicable

Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)

Completed

NCT02535624Not Applicable

Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures

Completed

NCT00793117Phase 4

The Effect of Packing in Post Operative Management of FESS

Completed

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4